Physician profile
Daniela C Castillo
NPI 1962167775
$755.97
in general payments reported to CMS, 2019-2025
17 companies · $346 in 2025
The $346 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $410 · 2025: $346.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $756.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $755.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $141.35 | 2024 | Inspiris Resilia Aortic Valve |
| Collegium Pharmaceutical, INC. | $141.22 | 2024 | Xtampza |
| Corcept Therapeutics | $72.07 | 2025 | Korlym |
| Glaxosmithkline, LLC. | $67.69 | 2024-2025 | Arexvy, Trelegy Ellipta |
| Lilly USA, LLC | $66.15 | 2024-2025 | Mounjaro, Zepbound |
| Exact Sciences Corporation | $36.15 | 2024-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Astellas Pharma US INC | $33.43 | 2025 | Veozah |
| Abbvie INC. | $30.36 | 2024-2025 | |
| Organon LLC | $28.45 | 2025 | Nexplanon |
| Bayer Healthcare Pharmaceuticals INC. | $24.21 | 2025 | |
| Dexcom, INC. | $22.92 | 2025 | Dexcom G6 Transmitter |
| Alvogen INC | $20.09 | 2025 | Teriparatide |
| Boehringer Ingelheim Pharmaceuticals, INC. | $15.91 | 2024 | Jardiance |
| Radius Health, INC. | $15.02 | 2025 | |
| Novo Nordisk INC | $14.53 | 2024 | Wegovy |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Antares Pharma, INC. | $13.47 | 2025 | Xyosted |
| Phathom Pharmaceuticals, INC. | $12.95 | 2025 | Voquezna |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniela Castillo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.